Stocks

Johnson & Johnson maintains steady guidance for 2026 in early January updates, reaffirming operational sales growth of 5-7% and adjusted...

Pfizer revenue outlook shows signs of stabilization and potential improvement for 2026, as the pharmaceutical giant navigates post-COVID transitions and...

Adobe shares rise on AI tools momentum in early January 2026, climbing amid upbeat fiscal 2026 guidance and accelerating monetization...

The FTSE 100 delivers its best year since 2009 with a 21.5% gain in 2025, outperforming Wall Street and European...

Russia's central bank halves its independent forex sales from 2026, reducing daily interventions to approximately 4.62 billion roubles and easing...

China's exceptional trade rally propels equities higher with record surplus surpassing $1 trillion fueled by export diversification to ASEAN and...

Meta Platforms delivers strong quarterly profits beating forecasts with robust ad revenue growth and AI-driven efficiencies offsetting infrastructure investments, signaling...

OTEGFX Breacher EA delivers consistent profits through advanced breakout algorithms and robust risk controls on MT4, empowering automated forex trading...

Citigroup board greenlights the sale of its remaining Russian operations to Renaissance Capital, incurring a substantial pre-tax loss while advancing...

US stocks conclude the year on a down note amid thin trading and profit-taking, yet secure solid double-digit gains overall,...